154 related articles for article (PubMed ID: 36313594)
1. Transcription factor SP1 regulates haptoglobin fucosylation via induction of GDP-fucose transporter 1 in the hepatoma cell line HepG2.
Kondo J; Sakata N; Morishita K; Hayashibara A; Sakon D; Takamatsu S; Asakura N; Suzuki T; Miyoshi E
Biochem Biophys Rep; 2022 Dec; 32():101372. PubMed ID: 36313594
[TBL] [Abstract][Full Text] [Related]
2. A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
Moriwaki K; Noda K; Nakagawa T; Asahi M; Yoshihara H; Taniguchi N; Hayashi N; Miyoshi E
Glycobiology; 2007 Dec; 17(12):1311-20. PubMed ID: 17884843
[TBL] [Abstract][Full Text] [Related]
3. An Alkynyl-Fucose Halts Hepatoma Cell Migration and Invasion by Inhibiting GDP-Fucose-Synthesizing Enzyme FX, TSTA3.
Kizuka Y; Nakano M; Yamaguchi Y; Nakajima K; Oka R; Sato K; Ren CT; Hsu TL; Wong CH; Taniguchi N
Cell Chem Biol; 2017 Dec; 24(12):1467-1478.e5. PubMed ID: 29033318
[TBL] [Abstract][Full Text] [Related]
4. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
[TBL] [Abstract][Full Text] [Related]
5. Vesicular Integral-Membrane Protein 36 Is Involved in the Selective Secretion of Fucosylated Proteins into Bile Duct-like Structures in HepG2 Cells.
Muranaka M; Takamatsu S; Ouchida T; Kanazawa Y; Kondo J; Nakagawa T; Egashira Y; Fukagawa K; Gu J; Okamoto T; Kamada Y; Miyoshi E
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108200
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor β signaling upregulates the expression of human GDP-fucose transporter by activating transcription factor Sp1.
Xu YX; Ma A; Liu L
PLoS One; 2013; 8(9):e74424. PubMed ID: 24069312
[TBL] [Abstract][Full Text] [Related]
7. Fucosylation is a promising target for cancer diagnosis and therapy.
Miyoshi E; Moriwaki K; Terao N; Tan CC; Terao M; Nakagawa T; Matsumoto H; Shinzaki S; Kamada Y
Biomolecules; 2012 Jan; 2(1):34-45. PubMed ID: 24970126
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of fucose into glycans independent of the GDP-fucose transporter SLC35C1 preferentially utilizes salvaged over de novo GDP-fucose.
Skurska E; Szulc B; Maszczak-Seneczko D; Wiktor M; Wiertelak W; Makowiecka A; Olczak M
J Biol Chem; 2022 Aug; 298(8):102206. PubMed ID: 35772493
[TBL] [Abstract][Full Text] [Related]
9. Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios.
Shang S; Li W; Qin X; Zhang S; Liu Y
J Cancer; 2017; 8(5):887-893. PubMed ID: 28382152
[TBL] [Abstract][Full Text] [Related]
10. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.
Asazawa H; Kamada Y; Takeda Y; Takamatsu S; Shinzaki S; Kim Y; Nezu R; Kuzushita N; Mita E; Kato M; Miyoshi E
Clin Chem Lab Med; 2015 Jan; 53(1):95-102. PubMed ID: 25060348
[TBL] [Abstract][Full Text] [Related]
11. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer.
Takeda Y; Shinzaki S; Okudo K; Moriwaki K; Murata K; Miyoshi E
Cancer; 2012 Jun; 118(12):3036-43. PubMed ID: 22006099
[TBL] [Abstract][Full Text] [Related]
12. In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2.
Lu L; Varshney S; Yuan Y; Wei HX; Tanwar A; Sundaram S; Nauman M; Haltiwanger RS; Stanley P
J Biol Chem; 2023 Dec; 299(12):105406. PubMed ID: 38270391
[TBL] [Abstract][Full Text] [Related]
13. Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.
Norton PA; Mehta AS
World J Gastroenterol; 2019 Jun; 25(23):2947-2960. PubMed ID: 31249452
[TBL] [Abstract][Full Text] [Related]
14. Biological function of fucosylation in cancer biology.
Miyoshi E; Moriwaki K; Nakagawa T
J Biochem; 2008 Jun; 143(6):725-9. PubMed ID: 18218651
[TBL] [Abstract][Full Text] [Related]
15. Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells.
Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Nakagawa T; Matsumoto H; Asahi M; Koyama N; Miyoshi E
Biochem Biophys Res Commun; 2008 Dec; 377(3):792-6. PubMed ID: 18951869
[TBL] [Abstract][Full Text] [Related]
16. FX enzyme and GDP-L-Fuc transporter expression in colorectal cancer.
Villar-Portela S; Muinelo-Romay L; Cuevas E; Gil-Martín E; Fernández-Briera A
Histopathology; 2013 Aug; 63(2):174-86. PubMed ID: 23730929
[TBL] [Abstract][Full Text] [Related]
17. Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells.
Nakagawa T; Moriwaki K; Terao N; Nakagawa T; Miyamoto Y; Kamada Y; Miyoshi E
J Proteome Res; 2012 May; 11(5):2798-806. PubMed ID: 22483194
[TBL] [Abstract][Full Text] [Related]
18. Slc35c2 promotes Notch1 fucosylation and is required for optimal Notch signaling in mammalian cells.
Lu L; Hou X; Shi S; Körner C; Stanley P
J Biol Chem; 2010 Nov; 285(46):36245-54. PubMed ID: 20837470
[TBL] [Abstract][Full Text] [Related]
19. Haptoglobin phenotype is a critical factor in the use of fucosylated haptoglobin for pancreatic cancer diagnosis.
Morishita K; Ito N; Koda S; Maeda M; Nakayama K; Yoshida K; Takamatsu S; Yamada M; Eguchi H; Kamada Y; Miyoshi E
Clin Chim Acta; 2018 Dec; 487():84-89. PubMed ID: 30189188
[TBL] [Abstract][Full Text] [Related]
20. ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.
Shang S; Qin X; Li W; Zhang S; Liu Y
Discov Med; 2016 Jan; 21(113):15-23. PubMed ID: 26896598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
